MindWalk Holdings (HYFT) Amortization - Intangibles (2021 - 2026)
MindWalk Holdings (HYFT) reported Amortization - Intangibles of $374.7 for Q1 2026, down 99.9% year-over-year from $366302.0 in Q1 2025, and up 2.52% quarter-over-quarter from $365.49 in Q4 2025.
MindWalk Holdings (HYFT) Amortization - Intangibles (2021 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has 6 years of Amortization - Intangibles data on file, last reported at $374.7 in Q1 2026.
- Amortization - Intangibles for Q1 2026 came in at $374.7, down 99.9% year-over-year; the trailing twelve-month figure through Jan 2026 was $1598.1 (down 100.0% YoY), and the FY2025 annual result was $2130.7, down 99.9% from the prior year.
- Amortization - Intangibles grew to $374.7 in Q1 2026 per HYFT's latest filing, from $365.49 in the prior quarter.
- Over five years, Amortization - Intangibles peaked at $634.6 million in Q3 2023 and troughed at $365.35 in Q3 2025.
- A 5-year average of $71.9 million and a median of $520679.9 in 2023 frame the typical range for Amortization - Intangibles.
- The sharpest annual moves came in 2023 and 2025: Amortization - Intangibles fell 26.92% in 2023, then tumbled 100.0% in 2025.
- A 5-year view of Amortization - Intangibles shows it stood at $717509.3 in 2022, then slipped by 26.92% to $524358.2 in 2023, then slipped by 29.2% to $371270.4 in 2024, then slumped by 99.9% to $365.49 in 2025, then increased by 2.52% to $374.7 in 2026.
- Business Quant data shows HYFT's Amortization - Intangibles at $374.7 in Q1 2026, $365.49 in Q4 2025, and $365.35 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | MindWalk Holdings | 166.20 Mn | 156.06 Mn | 1.78 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 374.70 |
| Oct 31, 2025 | 365.49 |
| Jul 31, 2025 | 365.35 |
| Apr 30, 2025 | 492.61 |
| Jan 31, 2025 | 366,301.96 |
| Oct 31, 2024 | 371,270.37 |
| Jul 31, 2024 | 366.62 Mn |
| Apr 30, 2024 | 517,001.71 |
| Jan 31, 2024 | 524,462.53 |
| Oct 31, 2023 | 524,358.15 |
| Jul 31, 2023 | 634.58 Mn |
| Apr 30, 2023 | 973,327.77 |
| Jan 31, 2023 | 765,860.44 |
| Oct 31, 2022 | 717,509.34 |
| Jan 31, 2021 | 727,699.13 |